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S U M M A R Y 
The present investigation was carried out on a sample of 840 children (5 to 
16 years old) from ten small towns of the State of Bahia in northeastern Brazil. 
The objetive was to study, by using a cross sectional methodology, the evolution 
of schistosomiasis morbidity (hepatic and splenic enlargement) in children, and 
the role of the intensity of S. mansoni infection in this process. The children 
were analised in three age groups (5 to 8, to 12 and 13 to 16 years old) and clas-
sified as uninfected, mildly infected, moderately infected and heavily infected 
according to the number of eggs in the stool. In children aged 5 to 8 years, increas-
ing egg counts were not associated with increasing frequencies of hepatic or sple-
nic enlargement. In the 9 to 12 years old group and association was observed with 
the prevalence of hepatic enlargement, but not with the prevalence of spleen en-
largement. In the oldest group, 13 to 16 years old, an association was observed 
with the prevalence of enlargement of both organs. It was evident that in this 
population schistosomiasis morbidity develops in the early period of life as a 
gradual process starting with liver enlargement and followed by spleen enlarge-
ment some years later. It was found that the intensity of infection has a funda-
mental role in this process, although there is a latent period of some years befo-
re clinical splenomegaly appears in moderate-heavily infected children. The Au-
thors suggest that the prevalence of splenomegaly in the 13 to 16 years old group 
is a good measure of the community level of schistosomiasis morbidity and could 
be used to measure the impact of control programs. 
I N T R O D U C T I O N 
Epidemiological studies on the evolution 
of morbidity caused by S. mansoni infection 
have demonstrated that the hepatosplenic 
form of the disease develops in most cases in 
the age group 10 to 20 years old 1 2 > w . Pathologi-
ca l 6 and cross sectional studies 2,7,11,15,21 have 
demonstrated an association between the in-
tensity of infection and the clinical severity of 
schistosomiasis. The present investigation ex-
plored the evolution of hepatic and splenic 
enlargement in children and the role of the in-
tensity of Schistosoma mansoni infection in 
this process, by using a cross-sectional me-
thodology. 
POPULATION AND METHODS 
The investigation was carried out in ten 
small towns of the State of Bahia in northeas-
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tern of Brazil. A sample of 976 children, 
between 5 and 16 years of age, was selected; 
the data were completed for 840 (86.3%). The 
male/female ratio in this sample was 0.95:1.00. 
The sampling design and the clinical and epi­
demiological methods were described elsewhe­
re 4 . Each child was provided with a labelled 
cup for subsequent collection of a fecal spe­
cimen. From each sample two thick smears 
were prepared, using the Kato technique as 
modified by KATZ et al.10. A commercially-
available Kit was used (Boehringer-Mannheim 
Bioquimica S.A., Rio de Janeiro, Brazil). 
The children were categorized, according 
to the number of eggs in the stool, as: unin­
fected, mildly infected (1-100 eggs/g of stool), 
moderately infected (101-400 eggs/g of stool) 
and heavily infected (401 or more eggs/g of 
stool). 
RESULTS 
The prevalence of infection increased with 
age (chi-square for trend = 34.15, p < 0.001) 
as well as the prevalence of splenomegaly 
(chi-square for trend = 5.12, p < 0.025), but 
not the prevalence of hepatomegaly (chi-squa­
re for trend = 0.06, p > 0.10) (Table I ) . 
Table I I presents the relationship between 
stool egg excretion and the prevalences of pal­
pable livers and spleens in the 3 age groups. 
In the 5-8 years old group, increasing egg counts 
were not associated with increasing frequen­
cies of hepatic and splenic enlargement (chi-
square for trend = 0.969, p > 0.10 and 0.586, 
p > 0.10, respectively). In the 9-12 years old 
group an association was observed with the 
prevalence of hepatic enlargement (chi-square 
for trend = 21.07, p < 0.001) but not with the 
prevalences of splenic enlargement (chi-squa­
re for trend = 0.264, p > 0.10). In the oldest 
group, 13 to 16 years, an association was ob­
served with the prevalences of enlargement 
for both organs (chi-square for trend = 5.01, 
p < 0.025 and 8.52, p < 0.01, respectively). 
The trend of increasing prevalence of hepatic 
and splenic enlargement with increasing age 
within each infection category was significant 
only for spleen enlargement (chi-square for 
trend = 7.97, p < 0.01) in the moderate-
heavy infected category (grouped together due 
to small numbers). 
DISCUSSION 
There are few longitudinal studies on the 
evolution of schistosomiasis mansoni morbi­
dity 2,12,13,19 and cross-sectional surveys have 
not usually focused on this question. More­
over, longitudinal studies have been done with 
different methodological approaches, thus mark­
ing it difficult to compare the results. 
Pathological studies of schistosomal sple­
nomegaly emphasize congestive and immuno­
logical (reticulo-endothelial hyperplasia) fac­
tors in its genesis u<s,2o. 
This cross-sectional study supports the 
evidence of a strong association between the 
individual S. mansoni worm burden as measur­
ed by the stool egg count and the prevalence 
of enlarged livers and spleens in children 7,n, 
15,21. Furthermore the present investigation 
shows the evolution of schistosomiasis man­
soni can be explored using this methodology. 
The arrangement of Table I I makes it pos­
sible to examine the results as longitudinal­
like data without the confounding influence 
of age. The unifected group can be conside­
red as a "control group" and the moderate-
heavily infected group as an "exposed group". 
In the "control group", the prevalences of sple­
nomegaly are stable in the 3 age groups. Whe­
reas the "exposed group" demonstrated a 
substantial and progressive increase in the pre­
valence of splenomegaly from 5 to 16 years 
of age. The association of S. mansoni egg 
counts with hepatomegaly began with the 9 to 
12 years old group, and with splenomegaly be­
gan with the next age group (13 to 16 years 
old) . These finding support the hypothesis 
of a latent period between the beginning of a 
moderate-heavy infection and the development 
of splenic enlargement as proposed by PRA-
TA & B I N A » . The latent period for liver en­
largement was some years shorter than that 
for spleen enlargement. 
The two different latent periods, and the 
observation that the prevalence of splenome­
galy increased with age in the moderate heavi­
ly infected group, demonstrated that in this 
young population clinically detectable splenic 
enlargement, occurred in most cases after en­
largement of the liver. These findings are con­
sistent with earlier observations that the de­
velopment of schistosomiasis morbidity in chil­
dren is a gradual phenomenon mediated by 
the intensity of the infection which can be in­
directly measured by the number of eggs in 
stool 6 . 
The fact that 13 to 16 years old demons­
trated both the highest prevalence of spleno­
megaly among those infected and an associa­
tion between the prevalence of splenomegaly 
and the intensity of infection (Table I I ) has 
practical consequences. The prevalences of 
splenomegaly in this age group should be 
one of the best indicators of the community 
level of schistosomiasis morbidity and could 
be used to evaluate the impact of control pro­
grams on the morbidity in a similar way that 
young children are used to monitor the im­
pact on transmission2 3. 
The high prevalence of schistosomal disea­
se detected in the study sample indicate the 
need for morbidity control"
 m the State of 
Bahia. Although we recognize the critical role 
of the worm burden in the development of 
morbidity and the importance of chemothera­
py to reduce morbidity s . , s , we are also aware 
that a dangerously high parasitic burden is 
more dependent on the social environment .than 
on the internae structure of the bodyM^X 
RESUMO 
O efeito da infecção pelo Schistosoma mansoni 
sobre a morbidade de crianças do Estado da 
Bahia, Brasil. II — Análise ao nível individual 
Foi estudada uma amostra de 840 crianças 
de 5 a 16 anos em 10 pequenas cidades do Es-
tado da Bahia. O objetivo foi, analisar, atra-
vés de um estudo de prevalência, as caracterís-
ticas evolutivas da morbidade esquistossomó¬ 
tica em crianças, bem como o papel da inten-
sidade da infecção pelo S. mansoni neste pro-
cesso. As crianças foram agregadas em 3 gru-
pos de idade (5-8, 9-12 e 13-16 anos) e foram 
classificadas com relação ao número de ovos 
excretados em: não infectados, infecção leve, 
infecção moderada e infecção grave. No grupo 
de 5 a 8 anos o aumento do número de ovos 
não se associou a uma maior prevalência de 
hepatomegalia ou esplenomegalia. No grupo 
de 9 a 12 anos observou-se uma associação com 
a prevalência de hepatomegalia mas não com 
a prevalência de esplenomegalia. No grupo de 
13 a 16 anos a associação foi observada com 
as prevalências de hepatomegalia e espleno-
megalia. Ficou evidente nesta população que, 
a morbidade esquistossomótica é um proces-
so gradual, que se inicia em uma etapa pre-
coce da vida e tem como primeiro sinal a he-
patomegalia, seguida pela esplenomegalia, 
após alguns anos. A intensidade da infecção 
tem um papel fundamental neste processo, po-
rém é necessário um período de latência de al-
guns anos para ocorrer o desenvolvimento de 
esplenomegalia clínica no grupo com infecção 
moderada ou grave. 
Os Autores propõem o uso da prevalência 
de esplenomegalia no grupo de 13 a 16 anos 
de idade como um bom indicador do nível 
de morbidade esquistossomótica na comunida-
de, útil para avaliar o impacto de programas 
de controle sobre a morbidade. 
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